| 000 | 01630 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514041208.0 | ||
| 264 | 0 | _c20021104 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0268-4705 | ||
| 024 | 7 |
_a10.1097/00001573-200207000-00002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKandzari, David E | |
| 245 | 0 | 0 |
_aTARGET versus GUSTO-IV: appropriate use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes and percutaneous coronary intervention. _h[electronic resource] |
| 260 |
_bCurrent opinion in cardiology _cJul 2002 |
||
| 300 |
_a332-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 | _aAbciximab |
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aAngina, Unstable _xdrug therapy |
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xtherapeutic use |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aTirofiban |
| 650 | 0 | 4 |
_aTyrosine _xanalogs & derivatives |
| 700 | 1 | _aCaliff, Robert M | |
| 773 | 0 |
_tCurrent opinion in cardiology _gvol. 17 _gno. 4 _gp. 332-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001573-200207000-00002 _zAvailable from publisher's website |
| 999 |
_c12038871 _d12038871 |
||